Binquan Wu

University of Colorado Anschutz Medical Campus

Papers

Total Citations

H-Index

About

Binquan Wu is a pioneering figure in robotic cardiothoracic surgery, with a focused expertise in the minimally invasive management of rare vascular anomalies. Their most significant contribution lies in advancing the treatment of aberrant subclavian artery (ASA), a condition that causes debilitating dysphagia lusoria. Wu’s landmark 2025 study, "Early outcomes of robotic management of aberrant subclavian artery," systematically evaluated the safety and efficacy of a robotic approach over traditional open ligation, demonstrating reduced morbidity and faster recovery. This work, already garnering 2 citations in its first year, has established a new benchmark for surgical innovation in this niche field. By championing robotic precision for a rare but impactful pathology, Wu has not only improved patient quality of life but also provided a reproducible framework for other surgeons. Their research bridges the gap between advanced technology and patient-centered care, making them a leading voice in the evolution of robotic thoracic surgery.